Understanding the role of exosomal lncRNAs in rheumatic diseases: a review

PeerJ. 2023 Dec 13:11:e16434. doi: 10.7717/peerj.16434. eCollection 2023.

Abstract

Rheumatic diseases, a group of diseases whose etiology is still unclear, are thought to be related to genetic and environmental factors, leading to complex pathogenesis. Based on their multi-system involvement, the diagnosis and treatment continue to face huge challenges. Whole-genome assays provide a distinct direction for understanding the underlying mechanisms of such diseases. Exosomes, nano-sized bilayer membrane vesicles secreted by cells, are mentioned as a key element in the physiological and pathological processes of the body. These exosomes mediate biologically active substances, such as nucleic acids, proteins, and lipids and deliver them to cells. Notably, long non-coding RNAs (lncRNAs), a unique class of non-coding RNAs, have been implicated in the pathogenesis of rheumatic diseases. However, the mechanism needs to be further explored. This article provided a comprehensive review of the findings on exosomal lncRNAs in rheumatic diseases, including rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, autoimmune liver diseases, primary dermatomyositis, and systemic sclerosis. Through in-depth understanding of these lncRNAs and their involved signaling pathways provide new theoretical supports for the diagnosis and treatment of rheumatic diseases.

Keywords: Exosome; LncRNA; Non-coding RNA; Rheumatology.

Publication types

  • Review

MeSH terms

  • Arthritis, Rheumatoid* / genetics
  • Autoimmune Diseases* / metabolism
  • Exosomes* / genetics
  • Humans
  • RNA, Long Noncoding* / genetics
  • Signal Transduction / genetics

Substances

  • RNA, Long Noncoding

Grants and funding

The authors received no funding for this work.